Hyaluronic acid new formulation: experience in HIV-associated facial lipoatrophy.


BACKGROUND Facial lipoatrophy (FLA) is a stigmatizing complication of antiretroviral therapy in patients with human immunodeficiency virus (HIV) infection. OBJECTIVES To evaluate the efficacy and safety of facial volume restoration in patients with HIV-associated FLA, using a novel long-lasting, hyaluronic acid high-density formulation. METHODS Twenty… (More)
DOI: 10.1159/000148252


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.